Center for Cardiovascular Research in Biomechanics - PROJECT SUMMARY – OVERALL
We propose to establish the Center for Cardiovascular Research in Biomechanics (CRiB), which will provide a
foundation for synergistic translational research activities aimed at developing novel materials and devices to
treat cardiovascular diseases. To maximize impact, the initial set of projects will focus on Peripheral Arterial
Disease (PAD) of the lower extremity arteries because PAD treatments continue to disappoint despite decades
of improvements and refinements in technologies and pharmacological adjuncts. The high rate of treatment
failures makes PAD one of the most expensive vascular diseases to treat on a per-patient basis, increasing the
urgency of developing better biomedical materials and devices. Our team has done extensive research in PAD,
and the strength of our approach is in the use of human tissues, large preclinical animal models, and diverse
multidisciplinary collaborations that enable the direct clinical translation of our discoveries. Support of the
COBRE will help us build a unique research environment with infrastructure to attract and train scientists in
translational cardiovascular biomechanics research. Our CRiB Center will be directed by a senior NIH R01-
funded investigator Dr. Alexey Kamenskiy who has built one of the largest databases of interlinked mechanical,
structural, and demographic characteristics of human arteries and used it to develop novel solutions to improve
clinical outcomes of vascular disease treatments. The CRiB Center will also include a unique Tissue Analysis
Core (TAC) dedicated to performing mechanical, structural, and biological evaluations of human, large animal,
and man-made materials, and directed by an NIH R01-funded scientist Dr. Anastasia Desyatova. The TAC will
support three projects by Research Project Leaders (RPLs) focused on the effects of sex on vascular
elastogenesis (RPL Majid Jadidi) and the development of devices for PAD surgical treatment and post-treatment
recovery using novel elastomeric bypass grafts (RPL Kaspars Maleckis) and ischemic wound dressings (RPL
Yury Salkovskiy). All three projects are based on solid preliminary data from humans and large animals and are
led by tenure-track Assistant Professors. Each RPL is mentored by two seasoned investigators: an NIH R01-
funded clinician-scientist to ensure translation, and a world-famous basic scientist from the RPL’s field of
expertise to advise on research strategy. The focus of our Center on research supporting the development of
devices and materials for vascular disease treatment is different from more traditional cellular and molecular-
based approaches and strategically utilizes our strengths in human artery biomechanics. With the help of the
COBRE, CRiB will create a novel biomedical research infrastructure with a direct translational focus that will
strengthen the technological and intellectual potential of our university, attract and retain talent, increase
interactions with the biomedical device industry, support many existing IDeA programs, and provide significant
benefits for the health of Nebraskans and society at large.